Panacea Biotech Fact Sheet, Panacea Biotech Financial Results - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Panacea Biotech Fact Sheet    (PANB)


Before 11:59pm TONIGHT: Get Our Most Important Research for Just Rs 2950 295


Here is the latest financial fact sheet of Panacea Biotech. For more details, see the Panacea Biotech quarterly results and Panacea Biotech share price and chart. For a sector overview, read our pharmaceuticals sector report.

PANACEA BIOTECH Price History

Price Rs 174.1
Mkt Cap Rs m 10,664
Vol '000 6.2
P/E X 7.8
P/CF X 11.2
EPS (TTM) Rs 22.3
% ch % -0.5
No. of shares m 61.25
% ch week % -3.7
% ch 1-mth % -10.3
% ch 12-mth % 26.8
52 week H/L Rs 263.0/90.0
(As on Oct 30, 2020 (Close))
* Results Consolidated
Excel EXPORT | DO YOU LIKE THESE FACTSHEETS? TELL US!

PANACEA BIOTECH Financials

No. of Mths
Year Ending
12
Mar-15
*
12
Mar-16
*
12
Mar-17
*
12
Mar-18
*
12
Mar-19
*
5-Yr Chart
Click to enlarge
PANACEA BIOTECH EQUITY SHARE DATA
High Rs219183178364354 
Low Rs958486129138 
Sales per share (Unadj.) Rs112.2106.688.896.874.6 
Earnings per share (Unadj.) Rs-17.4-3.0-6.7-12.06.7 
Diluted earnings per shareRs-17.4-3.0-6.7-12.06.7 
Cash flow per share (Unadj.) Rs-6.49.04.4-2.715.5 
Dividends per share (Unadj.) Rs00000 
Adj. dividends per shareRs0.000.000.000.000.00 
Dividend yield (eoy) %00000 
Book value per share (Unadj.) Rs74.365.958.150.457.2 
Adj. book value per shareRs74.365.958.150.457.2 
Shares outstanding (eoy) m61.2561.2561.2561.2561.25 
Bonus/Rights/Conversions  ----- 
Price / Sales ratio x1.41.31.52.53.3 
Avg P/E ratio x-9.0-44.7-19.8-20.536.8 
P/CF ratio (eoy) x-24.514.829.9-92.515.9 
Price / Book Value ratio x2.12.02.34.94.3 
Dividend payout %00000 
Avg Mkt Cap Rs m9,6078,1718,07915,10115,061 
No. of employees `0002.72.52.32.52.3 
Total wages/salary Rs m1,3601,4201,4811,5161,471 
Avg. sales/employee Rs Th2,537.62,613.42,406.12,401.91,973.6 
Avg. wages/employee Rs Th502.1568.3655.1614.2635.6 
Avg. net profit/employee Rs Th-393.3-73.2-180.8-298.2176.8 
PANACEA BIOTECH INCOME DATA
Net Sales Rs m6,8726,5315,4405,9284,567 
Other income Rs m2852044667845 
Total revenues Rs m7,1576,7345,9066,0064,612 
Gross profit Rs m4391,1176248632,030 
Depreciation Rs m672733680573540 
Interest Rs m1,0451,2731,0091,0061,048 
Profit before tax Rs m-994-686-599-637486 
Minority Interest Rs m1823000 
Prior Period Items Rs m-582300 
Extraordinary Inc (Exp) Rs m04977700 
Tax Rs m3119-1109977 
Profit after tax Rs m-1,065-183-409-736409 
Gross profit margin %6.417.111.514.644.4 
Effective tax rate %-3.1-2.818.3-15.515.9 
Net profit margin %-15.5-2.8-7.5-12.49.0 
PANACEA BIOTECH BALANCE SHEET DATA
Current assets Rs m5,2574,9915,3345,6032,415 
Current liabilities Rs m7,0604,6575,8816,9109,077 
Net working cap to sales %-26.25.1-10.1-22.0-145.9 
Current ratio x0.71.10.90.80.3 
Inventory Days Days16517221220665 
Debtors Days Days5269958471 
Net fixed assets Rs m12,99812,32110,3689,9418,333 
Share capital Rs m6161616161 
"Free" reserves Rs m4,4883,9743,4963,0263,443 
Net worth Rs m4,5494,0363,5573,0873,504 
Long term debt Rs m7,2307,8577,1415,707461 
Total assets Rs m19,30518,03018,00116,07613,755 
Interest coverage x00.50.40.41.5 
Debt to equity ratio x1.61.92.01.80.1 
Sales to assets ratio x0.40.40.30.40.3 
Return on assets %-0.16.03.31.710.6 
Return on equity %-23.4-4.5-11.5-23.811.7 
Return on capital %0.19.34.64.238.7 
Exports to sales %30.936.033.724.020.9 
Imports to sales %20.49.514.317.58.1 
Exports (fob) Rs m2,1252,3481,8321,424954 
Imports (cif) Rs m1,3996197801,040372 
Fx inflow Rs m2,3992,6981,9981,6001,203 
Fx outflow Rs m1,6739258981,131467 
Net fx Rs m7261,7731,101469736 
PANACEA BIOTECH CASH FLOW
From Operations Rs m 372 907 1,307 1,180 1,049 
From Investments Rs m -374 164 -258 553 -54 
From Financial Activity Rs m -7 -1,174 -1,070 -1,644 -1,011 
Net Cashflow Rs m -9 -103 -21 90 -20 
* Results Consolidated
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Share Holding

Indian Promoters 74.5%
Foreign collaborators 0.0%
Indian inst/Mut Fund 0.6%
FIIs 1.3%
ADR/GDR 0.0%
Free float 23.6%
Shareholders 10,259
Pledged promoter(s) holding 35.1%
 

Company Information

REGD OFF Ambala - Chandigarh Highway, Lalru, Punjab - 140 501
E-MAIL companysec@panaceabiotec.com WEB www.panaceabiotec.com
TELEPHONE (011) 4157 8024 FAX (011) 4167 9070
SECTOR PHARMACEUTICALS GROUP MISCELLANEOUS
TR AGENT Skyline Financial, D-153 A, Ist Flr., Okhla Indl. Area, Phase-I, New Delhi-20
AUDITOR S. R. Batliboi & Co.
CHM: Soshil Kumar Jain COMP SEC: Vinod Goel (GM-Legal) YEAR OF INC: 1985 BSE CODE: 531349 FV (Rs): 1 DIV YIELD (%): -

Read: PANACEA BIOTECH 2017-18 Annual Report Analysis

More Pharmaceuticals Company Fact Sheets:   FRESENIUS KABI ONCO.  DIVIS LABORATORIES  ALEMBIC PHARMA  INDRAPRASTHA MEDICAL  DR. REDDYS LAB  

Compare PANACEA BIOTECH With:   FRESENIUS KABI ONCO.  DIVIS LABORATORIES  ALEMBIC PHARMA  INDRAPRASTHA MEDICAL  DR. REDDYS LAB  

Compare PANACEA BIOTECH With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  




Today's Market

Sensex Ends 136 Points Lower; Telecom and Automobile Stocks Witness Selling(Closing)

Indian share markets witnessed volatile trading activity throughout the day and ended marginally lower.

Views on news

PANACEA BIOTECH 2017-18 Annual Report Analysis (Annual Result Update)

Mar 27, 2019 | Updated on Mar 27, 2019

Here's an analysis of the annual report of PANACEA BIOTECH for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of PANACEA BIOTECH. Also includes updates on the valuation of PANACEA BIOTECH.

PANACEA BIOTECH Announces Quarterly Results (3QFY19); Net Profit Down 137.1% (Quarterly Result Update)

Feb 22, 2019 | Updated on Feb 22, 2019

For the quarter ended December 2018, PANACEA BIOTECH has posted a net profit of Rs 230 m (down 137.1% YoY). Sales on the other hand came in at Rs 1 bn (down 25.2% YoY). Read on for a complete analysis of PANACEA BIOTECH's quarterly results.

PANACEA BIOTECH Announces Quarterly Results (2QFY19); Net Profit Down 1631.6% (Quarterly Result Update)

Nov 27, 2018 | Updated on Nov 27, 2018

For the quarter ended September 2018, PANACEA BIOTECH has posted a net profit of Rs 975 m (down 1631.6% YoY). Sales on the other hand came in at Rs 1 bn (down 22.3% YoY). Read on for a complete analysis of PANACEA BIOTECH's quarterly results.

More Views on News

Most Popular

My View on ITC (Fast Profits Daily)

Oct 23, 2020

What do the charts say about ITC?

PSU Banks Will Move Up Again (Profit Hunter)

Oct 27, 2020

My charts tell me PSU banks are set for a rebound.

PSU Stocks Are Looking Positive Now (Fast Profits Daily)

Oct 19, 2020

Has the market changed its opinion on PSUs?

One Cycle that Defines Everything in Markets (Profit Hunter)

Oct 23, 2020

Know this cycle to boost your profits in the market.

Markets are Always Right? (The Honest Truth)

Oct 30, 2020

Ajit Dayal on why you shouldn't let your guard down as an investor.

More

Covid-19 Proof
Multibagger Stocks

Covid19 Proof Multibaggers
Get this special report, authored by Equitymaster's top analysts now!
We will never sell or rent your email id.
Please read our Terms

TRACK PANACEA BIOTECH

  • Track your investment in PANACEA BIOTECH with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON PANACEA BIOTECH

PANACEA BIOTECH 8-QTR ANALYSIS

COMPARE PANACEA BIOTECH WITH

MARKET STATS